Does EVOLOCUMAB Cause Blood glucose abnormal? 132 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Blood glucose abnormal have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
132
Reports of Blood glucose abnormal with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
1
Deaths
13
Hospitalizations
How Dangerous Is Blood glucose abnormal From EVOLOCUMAB?
Of the 132 reports, 1 (0.8%) resulted in death, 13 (9.8%) required hospitalization.
Is Blood glucose abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 132 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Blood glucose abnormal?
INSULIN GLARGINE (2,463)
INSULIN LISPRO (2,460)
DULAGLUTIDE (912)
INSULIN HUMAN (900)
METFORMIN (563)
EXENATIDE (556)
EMPAGLIFLOZIN (445)
SITAGLIPTIN (334)
ADALIMUMAB (285)
DEVICE (269)
Which EVOLOCUMAB Alternatives Have Lower Blood glucose abnormal Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE